These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 29282304

  • 1. Type 2 Cysteinyl Leukotriene Receptors Drive IL-33-Dependent Type 2 Immunopathology and Aspirin Sensitivity.
    Liu T, Barrett NA, Kanaoka Y, Yoshimoto E, Garofalo D, Cirka H, Feng C, Boyce JA.
    J Immunol; 2018 Feb 01; 200(3):915-927. PubMed ID: 29282304
    [Abstract] [Full Text] [Related]

  • 2. Cysteinyl leukotriene receptor 2 drives lung immunopathology through a platelet and high mobility box 1-dependent mechanism.
    Liu T, Barrett NA, Kanaoka Y, Buchheit K, Laidlaw TM, Garofalo D, Lai J, Katz HR, Feng C, Boyce JA.
    Mucosal Immunol; 2019 May 01; 12(3):679-690. PubMed ID: 30664709
    [Abstract] [Full Text] [Related]

  • 3. Leukotriene D4 paradoxically limits LTC4-driven platelet activation and lung immunopathology.
    Liu T, Barrett NA, Nagai J, Lai J, Feng C, Boyce JA.
    J Allergy Clin Immunol; 2021 Jul 01; 148(1):195-208.e5. PubMed ID: 33285161
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Aspirin-Exacerbated Respiratory Disease Involves a Cysteinyl Leukotriene-Driven IL-33-Mediated Mast Cell Activation Pathway.
    Liu T, Kanaoka Y, Barrett NA, Feng C, Garofalo D, Lai J, Buchheit K, Bhattacharya N, Laidlaw TM, Katz HR, Boyce JA.
    J Immunol; 2015 Oct 15; 195(8):3537-45. PubMed ID: 26342029
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Factors driving the aspirin exacerbated respiratory disease phenotype.
    Steinke JW, Borish L.
    Am J Rhinol Allergy; 2015 Oct 15; 29(1):35-40. PubMed ID: 25590316
    [Abstract] [Full Text] [Related]

  • 12. Cutting edge: Leukotriene C4 activates mouse platelets in plasma exclusively through the type 2 cysteinyl leukotriene receptor.
    Cummings HE, Liu T, Feng C, Laidlaw TM, Conley PB, Kanaoka Y, Boyce JA.
    J Immunol; 2013 Dec 15; 191(12):5807-10. PubMed ID: 24244016
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. MicroRNA-155 is a critical regulator of type 2 innate lymphoid cells and IL-33 signaling in experimental models of allergic airway inflammation.
    Johansson K, Malmhäll C, Ramos-Ramírez P, Rådinger M.
    J Allergy Clin Immunol; 2017 Mar 15; 139(3):1007-1016.e9. PubMed ID: 27492144
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cysteinyl leukotriene E4 activates human group 2 innate lymphoid cells and enhances the effect of prostaglandin D2 and epithelial cytokines.
    Salimi M, Stöger L, Liu W, Go S, Pavord I, Klenerman P, Ogg G, Xue L.
    J Allergy Clin Immunol; 2017 Oct 15; 140(4):1090-1100.e11. PubMed ID: 28115217
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.